Olema Pharmaceuticals, Inc.

13.48 USD
-0.01 (-0.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Olema Pharmaceuticals, Inc. stock is up 20.79% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 1 CALL, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Jan 19:56 19 Jan, 2024 7.50 CALL 218 16
15 Feb 15:26 15 Mar, 2024 20.00 PUT 143 0

About Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of therapies for women's cancers. OP-1250, an estrogen receptor antagonist and a selective ER degrader, is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.